首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

1169179

鼻腔給藥系統市場：按劑型、容器類型、系統類型、治療應用、分銷渠道、區域 - 規模、份額、展望、機會分析，2022-2030 年

Nasal Drug Delivery Systems Market, by Dosage Form, by Container Type, by System Type, by Therapeutics Application, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年11月08日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

鼻腔正在成為最有潛力和最有前途的藥物輸送途徑之一，因為它具有避免肝臟初級代謝和最重要的患者便利等優勢。鼻腔給藥系統用於治療疼痛、急性偏頭痛、過敏性和非過敏性鼻炎、鼻竇炎、感冒和鼻炎引起的鼻塞。當需要起效或其他給藥途徑失敗時，通常採用鼻內給藥。鼻腔給藥系統可實現全身給藥和無針疫苗接種。液體滴鼻劑可以使用吸入器、滴管、噴霧泵、霧化器和霧化器給藥。

市場動態

鼻腔給藥系統研發活動的增加預計將在預測期內推動全球鼻腔給藥系統市場的增長。例如，2022 年 4 月 5 日，總部位於英國的合同開發和製造組織 (CDMO) Upperton Pharma Solutions 宣布，中小型創新者將擁有成功開發鼻用製劑所需的知識和能力。我們推出鼻腔給藥開發平台“UpperNose”供使用。

此外，預計在預測期內，監管機構對產品批准的增加將推動鼻腔給藥市場的增長。例如，2021 年 10 月 18 日，處於商業化階段的生物製藥公司 Oyster Point Pharma, Inc. 宣布，美國食品藥品監督管理局 (FDA) 批准 TYRVAYA（伐尼克蘭溶液）鼻腔噴霧劑 0.03 mg 用於以下症狀和體徵：乾眼症。宣布獲批用於治療它是第一個也是唯一一個被批准用於治療乾眼症的鼻腔噴霧劑。通過與膽鹼能受體結合併激活三叉神經系統的副交感神經通路，據信可以增加基礎淚液的產生，從而治療乾眼症。

這項研究的主要特點

本報告對全球鼻腔給藥系統市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。
它還闡明了各個細分市場的潛在創收機會，並描述了該市場具有吸引力的投資建議矩陣。
它還提供關鍵見解，例如市場驅動因素和製約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
它根據以下參數介紹了全球鼻腔給藥系統市場的領先企業：公司亮點、產品組合、主要亮點、財務業績和戰略。
本研究涵蓋的主要公司包括默克公司、葛蘭素史克公司、阿斯利康公司、強生公司、輝瑞公司、百特國際公司、威朗製藥國際公司、Becton、狄金森公司和諾華公司
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球鼻腔給藥系統市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第2章市場展望

報告內容
- 市場定義和範圍
執行摘要
- 市場概況：按劑型分類
- 按容器類型分類的市場概況
- 市場概況：按系統類型
- 市場概況：按治療用途分類
- 市場概況：按分銷渠道
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 市場機會
主要亮點
市場趨勢
害蟲分析
政府和非政府倡議
流行病學

第 4 章全球鼻腔給藥系統市場——冠狀病毒 (COVID-19) 大流行的影響

總體影響
政府舉措
COVID-19 對市場的影響

第 5 章全球鼻腔給藥系統市場，按配方分列，2017-2030

噴鼻劑
滴鼻劑
鼻用凝膠
鼻粉
其他

第 6 章按容器類型分列的鼻腔給藥系統全球市場，2017-2030

常壓容器
壓力容器

第 7 章全球鼻腔給藥系統市場：按系統類型，2017-2030

2022 年和 2030 年市場份額分析 (%)
2017-2030 年同比增長率分析
細分趨勢

多劑量
- 2017-2030 年市場規模、預測、同比增長率
雙倍劑量
- 2017-2030 年市場規模、預測、同比增長率
單位劑量
- 2017-2030 年市場規模、預測、同比增長率

第 8 章全球鼻腔給藥系統市場：按治療用途分類，2017-2030

2022 年和 2030 年市場份額分析 (%)
2017-2030 年同比增長率分析
細分趨勢

過敏性和非過敏性鼻炎
- 2017-2030 年市場規模、預測、同比增長率
鼻塞
- 2017-2030 年市場規模、預測和同比增長率
疫苗
- 2017-2030 年市場規模、預測、同比增長率
其他
- 2017-2030 年市場規模和預測，同比增長率

第 9 章全球鼻腔給藥系統市場：按分銷渠道，2017-2030

2022 年和 2030 年市場份額分析 (%)
2017-2030 年同比增長率分析
細分趨勢

醫院藥房
- 2017-2030 年市場規模、預測、同比增長率
零售藥房
- 2017-2030 年市場規模、預測、同比增長率
在線藥店
- 2017-2030 年市場規模和預測，同比增長率

第 10 章按地區分列的鼻腔給藥系統全球市場，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲地區
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第11章競爭格局

熱圖分析
市場份額分析
公司簡介
- Merck & Co., Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- Johnson & Johnson
- Pfizer Inc.
- Baxter International, Inc.
- Valeant Pharmaceuticals International, Inc.
- Becton, Dickinson and Company
- Novartis AG

第12章章節

調查手法介紹
關於出版社

簡介目錄

Product Code: CMI1944

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The nasal drug delivery systems used in the treatment of pain, acute migraine treatment, allergic and non-allergic rhinitis, and nasal congestion brought on by sinusitis, the common cold, or rhinitis. Nasal medication delivery is typically employed when a beginning of action is desired or when other routes of administration prove unsuccessful. Systemic drug administration and needle-free immunization is possible with the help of nasal drug delivery systems. It is possible to use inhalers, droppers, spray pumps, nebulizers, or atomizers to give liquid nasal solutions.

Market Dynamics

Increasing research and development activities for nasal drug delivery systems is expected to drive growth of the global nasal drug delivery system market over the forecast period. For instance, on April 5, 2022, Upperton Pharma Solutions, a U.K. based contract development and manufacturing organization (CDMO) had launched a nasal delivery development platform, UpperNose, for small and mid-sized innovators to access the knowledge and capabilities required for the successful development of nasal dose formulations.

Furthermore, increasing product approvals by regulatory authorities is expected to drive growth of the nasal drug delivery market over the forecast period. For instance, on October 18, 2021, Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company had announced that the U.S. Food and Drug Administration (FDA) had approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray approved for the treatment of dry eye disease. TYRVAYA Nasal Spray is believed to bind to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease.

Key features of the study:

This report provides an in-depth analysis of the global nasal drug delivery systems market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nasal drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nasal drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery systems market

Detailed Segmentation:

Global Nasal Drug Delivery Systems Market, By Dosage Form:
- Nasal Spray
- Nasal Drops
- Nasal Gels
- Nasal Powders
- Others
Global Nasal Drug Delivery Systems Market, By Container Type:
- Non-pressurized Containers
- Pressurized Containers
Global Nasal Drug Delivery Systems Market, By System Type
- Multi Dose
- Bi Dose
- Unit Dose
Global Nasal Drug Delivery Systems Market, By Therapeutics Application:
- Allergic and Non-allergic Rhinitis
- Nasal Congestion
- Vaccination
- Others
Global Nasal Drug Delivery Systems Market, By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Nasal Drug Delivery Systems Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Merck & Co., Inc. *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
- AstraZeneca plc
- Johnson & Johnson
- Pfizer Inc.
- Baxter International, Inc.
- Valeant Pharmaceuticals International, Inc.
- Becton, Dickinson and Company
- Novartis AG.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By System Type
- Market Snapshot, By Therapeutics Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Key Highlights
Market Trends
PEST Analysis
Government & Non-Government Initiatives
Epidemiology

4. Global Nasal Drug Delivery Systems Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Nasal Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Nasal Drops
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Nasal Gels
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Nasal Powders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Nasal Drug Delivery Systems Market, By Container Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Non-Pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Nasal Drug Delivery Systems Market, By System Type, 2017 - 2030, (US$ Million)

Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends

Multi Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Bi-Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Unit Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2017 - 2030, (US$ Million)

Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends

Allergic and Non-Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Nasal Congestion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

9. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 - 2030
Segment Trends

Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

10. Global Nasal Drug Delivery Systems Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa